• Latest Posts

Roche Partners with French Startup to Diagnose Septic Shock

Roche Abandons Spanish Cancer Epigenetics Drug

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

In Depth 24 May 2017

What Happens when the Immune System Attacks Life-Saving Drugs?

Roche’s Checkpoint Inhibitor Misfires in Late-Stage Trials


The Top 12 Biotech Leaders You Should Know in Basel

How is Biotech Transforming Pharma’s R&D Model?

Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?

Which European Blockbusters Topped the Charts in 2016?

Hopes are up: A Second Phase III Trial for Alzheimer’s Disease

Biosimilars set to take on Oncology after a new Market Authorization